首页 | 本学科首页   官方微博 | 高级检索  
     


The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre,single‐arm,open‐label study of etravirine and darunavir/ritonavir as dual therapy in HIV‐1‐infected early treatment‐experienced subjects
Authors:PJ Ruane  C Brinson  M Ramgopal  R Ryan  B Coate  M Cho  TN Kakuda  D Anderson
Affiliation:1. Peter J. Ruane MD Inc., Los Angeles, CA, USA;2. Central Texas Clinical Research, Austin, TX, USA;3. Midway Immunology and Research Center, Fort Pierce, FL, USA;4. Janssen Research & Development, Titusville, NJ, USA;5. Janssen Scientific Affairs, LLC, Titusville, NJ, USA
Abstract:
Keywords:darunavir  etravirine  HIV‐1  nucleoside‐sparing  race  treatment‐experienced
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号